Stanley Druckenmiller's NUVB Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 4.54 M shares of Nuvation Bio Inc. (NUVB) worth $19.48 M, representing 0.58% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Stanley Druckenmiller has initiated a new position in NUVB, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Nuvation Bio (NUVB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nuvation Bio (NUVB) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +4.54 M | New Buy | 4.54 M | $4.29 |
Stanley Druckenmiller's Nuvation Bio Investment FAQs
Stanley Druckenmiller first purchased Nuvation Bio Inc. (NUVB) in Q1 2026, acquiring 4,539,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Nuvation Bio Inc. (NUVB) for 1 quarters since Q1 2026.
Stanley Druckenmiller's largest addition to Nuvation Bio Inc. (NUVB) was in Q1 2026, adding 4,539,800 shares worth $19.48 M.
According to the latest 13F filing for Q1 2026, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 4,539,800 shares of Nuvation Bio Inc. (NUVB), valued at approximately $19.48 M.
As of the Q1 2026 filing, Nuvation Bio Inc. (NUVB) represents approximately 0.58% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in Nuvation Bio Inc. (NUVB) was 4,539,800 shares, as reported at the end of Q1 2026.